Growing community of inventors

Millbrae, CA, United States of America

David L Bourdet

Average Co-Inventor Count = 5.65

ph-index = 1

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 5

David L BourdetAdam D Hughes (3 patents)David L BourdetMelissa Fleury (3 patents)David L BourdetMiroslav Rapta (3 patents)David L BourdetVenkat R Thalladi (3 patents)David L BourdetR Michael Baldwin (3 patents)David L BourdetGene Timothy Fass (1 patent)David L BourdetAi Ling Ching (1 patent)David L BourdetMichael Simeone (1 patent)David L BourdetMarie T Borin (1 patent)David L BourdetArthur Lo (1 patent)David L BourdetMelissa Fleury (1 patent)David L BourdetDavid L Bourdet (4 patents)Adam D HughesAdam D Hughes (136 patents)Melissa FleuryMelissa Fleury (92 patents)Miroslav RaptaMiroslav Rapta (62 patents)Venkat R ThalladiVenkat R Thalladi (42 patents)R Michael BaldwinR Michael Baldwin (3 patents)Gene Timothy FassGene Timothy Fass (8 patents)Ai Ling ChingAi Ling Ching (5 patents)Michael SimeoneMichael Simeone (3 patents)Marie T BorinMarie T Borin (1 patent)Arthur LoArthur Lo (1 patent)Melissa FleuryMelissa Fleury (2 patents)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Theravance Biopharma R&d Ip, LLC (4 from 262 patents)


4 patents:

1. 12351561 - Crystalline (2S,4R)-5-(5'-chloro-2'-fluoro-[1,1'-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

2. 11718591 - Crystalline (2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2- methylpentanoic acid and uses thereof

3. 11471442 - Administration of gut-selective JAK3 inhibitor

4. 10472335 - Crystalline(2S,4R)-5-(5'-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/25/2025
Loading…